Auditocity is thrilled to announce that we have successfully raised $100,000 in our latest funding round, a momentous milestone that marks a significant step forward in our mission to revolutionize human resources compliance for businesses of all sizes. As the only human resources SaaS platform of its kind, Auditocity has redefined HR auditing by automating and streamlining compliance processes, ensuring companies—from innovative startups to Fortune 500 giants—remain up-to-date with the latest regulations while protecting their bottom line. This new capital injection will be strategically deployed to enhance our core features, such as automated compliance workflows and real-time reporting. These enhancements not only simplify complex compliance landscapes but also offer a more intuitive and secure experience, empowering both technical and non-technical users to effortlessly manage their regulatory obligations. Moreover, the funding will bolster our ongoing efforts to improve the overall usability and security of our platform, ensuring top-tier protection and seamless integration with diverse business systems. With over 10,000 businesses worldwide already trusting Auditocity to safeguard their operations, this investment reflects our stakeholders’ confidence in our vision and the potential to drive further innovation in the HR compliance space. Ultimately, this funding round accelerates our plans to scale our services, extend our market reach, and invest in cutting-edge technology that further automates compliance, reduces risk, improves operational efficiency, and yields significant cost savings for businesses everywhere. We are excited to embark on this next chapter of growth and innovation, continually demonstrating our commitment to making HR auditing effortless and effective for every business.
Auditocity Secures $100K Funding to Revolutionize HR Compliance Worldwide
Get the full Auditocity company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Alitheon
Alitheon provides the last solution you will need for identification, authentication, and traceability of parts and products with our fail-proof, simple-to-use FeaturePrint system. FeaturePrint is an advanced machine-vision technology that provides for items, what fingerprints are for people – a unique and persistent identifier for the one in millions. FeaturePrint serializes items. As such, it enables track & trace, eliminates counterfeits and gray markets, and reduces human error ....all with just a photo using a standard camera. No bar codes, No QR codes, No stickers, No tags, No 'invisible' dust, No markers, No holograms, No special cameras, No special lighting, No Nonsense!
$8.0M Series a
today
The Ryl Company™
The Ryl Company™ is The Modern Tea Company — where nostalgic taste, clean ingredients, and functional benefits come together. Our flagship brand, Ryl Tea, reimagines the classic tea experience with zero sugar, 5 calories or less, nothing artificial, and antioxidant-powered functionality. We believe better-for-you should taste like the flavors you grew up loving. That’s why we exist: to help people Rethink Your Liquids (RYL). Available nationwide.
$20.0M Series c
today
Tavo Biotherapeutics
Tavo Biotherapeutics is developing innovative treatments to address critical unmet needs in ophthalmology. TAV-001 engages two novel targets that represent fundamental mechanisms underlying the pathology of glaucoma-related neurodegeneration. In pre-clinical studies, TAV-001 has shown signals of neuroprotection as well as substantial reduction in intraocular pressure, suggesting that it could represent the first disease-modifying pharmaceutical therapy for these patients. TAV-001 is expected to enter a Phase 1 clinical trial in glaucoma patients in 2025. TAV-002 represents a potential first-in-class treatment for retinal disease, including diabetic retinopathy, diabetic macular edema, and both wet and dry age-related macular degeneration. Tavo has initiated IND-enabling activities for this program.
$17.0M Series a
today
Adaptive Innovations Corp
Adaptive Innovations is an engineering firm and system integrator specializing in the design, fabrication, integration, and installation of custom equipment, automation & robotic solutions, tooling, fixtures, and gages. Comprised of a diverse group of professional engineers with backgrounds in design, controls, manufacturing, and electrical engineering disciplines, our outstanding team can help position your company to compete in today’s global economy. Combining industry best designs with exceptional process knowledge, fed by cross-industry exposure, Adaptive sets itself apart from its competition through every step of a project. We have a history of consistently delivering cost effective solutions, an excellent on-time delivery record, and unparalleled customer service, making Adaptive the engineering partner you can count on. Adaptive is considered the market leader in the design and fabrication of environmental test fixtures for testing such as HALT/HASS, ESS, and ED vibration or combined environments. We have experience with a wide array of automated solutions, including, assembly, pick-n-place, adhesive dispense, soldering, sorting, inspection etc. We're a Fanuc approved integrator, and have also integrated robots from ABB, Epson, Denso, and Adept. Our controls engineers are familiar with Beckhoff, Allen Bradley, Fanuc, Siemens, Mitsubishi, and National Instruments, contrllers and have a wide range of experience with robotic applications.
$50.0M Series a
today
Mia Health
Mia Health provides accurate risk assessments of large groups or populations which is crucial for the efficiency and resource optimization of health systems. With our customizable rapid screening and risk stratification platform you can now scale health systems significantly for more efficient and cost-effective population health management. Mia Health enables anyone to rapidly screen and stratify patient risk profiles using data collected through a smartphone in just 60 seconds. By measuring key vitals and providing critical insights to inform clinical or systemic decision-making, Mia Health simultaneously enables patient recommendations once a clinical decision has been made. Our proprietary cognitive AI encodes the expertise of dozens of world leading physicians making the Mia Health platform the most informed health stratification tool in the world and the only one of its kind. This eagerly anticipated and desperately needed technology is drastically closing the gap on delivering accessible, equitable care to all those who need it regardless of geographic location, economic status, race or gender. Learn More: https://www.miahealth.io
$920.0K Seed
today